Document is current
Any future updates will be listed below
-
Authors
Park, So Jung
Frake, Rebecca A. https://orcid.org/0000-0003-2016-2368
Karabiyik, Cansu
Son, Sung Min
Siddiqi, Farah H.
Bento, Carla F.
Sterk, Peter
Vicinanza, Mariella
Pavel, Mariana https://orcid.org/0000-0002-2802-5993
Rubinsztein, David C. https://orcid.org/0000-0001-5002-5263
-
Funding
Funding for this research was provided by:
University of Cambridge | James Baird Fund, University of Cambridge (NA)
Sims Fund Frank Edward Elmore Fund
Gates Cambridge Trust (NA)
Romanian grant from ministry of Research and Innovation
Fondation Roger de Spoelberch (N/A)
Wellcome Trust (095317/Z/11/Z, 100140/Z/12/Z)
EC | EC Seventh Framework Programm | FP7 Health (2012-305121)
UK Dementia Research Institute
- License Information
-
More Information
Article History
Received: 23 April 2021
Revised: 11 November 2021
Accepted: 12 November 2021
First Online: 30 November 2021
Competing interests
: CFB is currently employed by Astex Pharmaceuticals, UK. MV is currently employed by GlaxoSmithKline Pharmaceutical, UK. DCR is a consultant for Aladdin Healthcare Technologies SE, Nido Biosciences and Drishti Discoveries. All other authors declare no potential conflict of interest.
: All mouse studies and procedures were performed under the jurisdiction of appropriate UK Home Office Project and Personal Animal Licenses and with the approval of the University of Cambridge Animal Welfare and Ethical Review Body.
